Viking Therapeutics (VKTX) Misses Q1 EPS by 35c

Viking Therapeutics (NASDAQ: VKTX) reported Q1 EPS of ($1.37), $0.35 worse than the analyst estimate of ($1.02).

For earnings history and earnings-related data on Viking Therapeutics (VKTX) click here.

You May Also Be Interested In

• Citi upgrades Bath & Body Works to Buy with $25 price target
• Duos Technologies Group, Inc. (DUOT) Tops Q2 EPS by 163c
• Carvana's share gains and production growth remain on track, Wells Fargo says